We have observed
5 EP applications
Thomas Kurt Ritter
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after July 17, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
PHENETHYLSULFONE ISOINDOLINE DERIVATIVES AS INHIBITORS OF PDE 4 AND/OR CYTOKINES
PHARMACEUTICAL FORMULATIONS OF A SUBSTITUTED DIAMINOPURINE
PROCESSES FOR PREPARING ISOQUINOLINONES AND SOLID FORMS OF ISOQUINOLINONES
SALTS OF ARYLSULFONAMIDE CCR3 ANTAGONISTS
CRYSTALINE (8S,9R)-5-FLUORO-8-(4-FLUOROPHENYL)-9-(1-METHYL-1H-1,2,4-TRIAZOL-5-YL)-8,9-DIHYDRO-2H-PYRIDO[4,3,2-DE]PHTALAZIN-3(7H)-ONE TOSYLATE SALT